Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

Todd Neale

October 02, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Shelley Wood

August 15, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Daily News

‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum

Todd Neale

April 27, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Advertisement

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

FDA Approves Triple Therapy Polypill for High Blood Pressure

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Guideline-Directed Therapies Underused in Frail HF Patients

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Observational Study Supports Continuing Oral Anticoagulation During PCI

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

New Review Probes Possibility of CVD Prevention Without Aspirin

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content